Qiagen quickly ticks higher amid takeover speculation

Sascha Schuermann/Getty Images News Qiagen ( NYSE: QGEN ) quickly rose 1.3% amid a report that the diagnostics company is seeing some renewed takeover talk. Qiagen ( QGEN ) is said to have attracted a new round of interest from a potential buyer, according to a Betaville "uncooked alert" on Tuesday.

The renewed takeover chatter comes after the company held talks with potential buyers a few years ago. Thermo Fisher ( TMO ) and France's Biomerieux SA were reported to have discussions with Qiagen ( QGEN ). In August 2020 Thermo Fisher ( TMO ) walked away from a €43.00 per share offer for diagnostic test maker Qiagen ( QGEN ).

Thermo Fisher first announced a €39/share offer for QGEN in March 2020, then upped its bid after institutional investors rebelled over the price. Bloomberg originally reported in November 2021 that Qiagen ( QGEN ) attracted the buyout interest of French diagnostics company bioMérieux. Qiagen ( QGEN ) is scheduled to report Q4 results on Feb.

6. More on Qiagen Qiagen N.V. (QGEN) Q3 2023 Earnings Call Transcript FDA OKs Qiagen's NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems QIAGEN expands business in Middle East with new regional headquarters Seeking Alpha’s Quant Rating on Qiagen Historical earnings data for Qiagen.